Literature DB >> 22991424

Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE.

S Paltansing1, M E M Kraakman, J M C Ras, E Wessels, A T Bernards.   

Abstract

OBJECTIVES: To characterize the mechanisms of fluoroquinolone and cephalosporin resistance in Enterobacteriaceae from a Dutch teaching hospital in 2008.
METHODS: We sequenced gyrA, gyrB, parC and parE. The presence of plasmid-encoded genes qnrA, qnrB, qnrS, aac(6')-Ib, qepA, bla(TEM), bla(SHV,) bla(OXA), bla(CTX-M) and bla(AmpC) was studied by PCR. Escherichia coli isolates were further characterized by AFLP and multilocus sequence typing (MLST).
RESULTS: In total, 49 E. coli, 16 Klebsiella pneumoniae and 3 Enterobacter cloacae isolates were investigated. Mutations in gyrA were found in all E. coli isolates. Forty-five (92%) E. coli isolates carried at least one point mutation in parC. Most E. coli isolates (59%) also carried mutations in parE, of which I529L was the most prevalent. I529L was unequivocally associated with E. coli sequence type (ST) 131. This single-nucleotide polymorphism (SNP) was later also found in eight out of nine ST131 strains from another collection. Twenty-nine E. coli isolates carried extended-spectrum β-lactamase (ESBL) genes, predominantly bla(CTX-M-15). In E. coli, aac(6')-Ib-cr was the predominant plasmid-mediated resistance mechanism, whereas in K. pneumoniae qnr genes were found mostly. In K. pneumoniae isolates, qnr and aac(6')-Ib-cr co-occurred with ESBL genes (n = 13; bla(CTX-M) and bla(SHV)) and/or bla(AmpC) (n = 3; bla(DHA-1)).
CONCLUSIONS: E. coli ST131 was the predominant clone, which accumulated a high number of chromosomal mutations. The I529L SNP in parE was a signature of most, but not all, ST131 strains. In contrast to E. coli, fluoroquinolone resistance mechanisms were predominantly plasmid-encoded in K. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22991424     DOI: 10.1093/jac/dks365

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

Review 1.  Plasmid-mediated quinolone resistance.

Authors:  George A Jacoby; Jacob Strahilevitz; David C Hooper
Journal:  Microbiol Spectr       Date:  2014-10

2.  In vitro activity of ceftolozane-tazobactam as determined by broth dilution and agar diffusion assays against recent U.S. Escherichia coli isolates from 2010 to 2011 carrying CTX-M-type extended-spectrum β-lactamases.

Authors:  Mark Estabrook; Brianne Bussell; Susan L Clugston; Karen Bush
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

3.  Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.

Authors:  James R Johnson; Brian Johnston; Michael A Kuskowski; Evgeni V Sokurenko; Veronika Tchesnokova
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

4.  Quinolone co-resistance in ESBL- or AmpC-producing Escherichia coli from an Indian urban aquatic environment and their public health implications.

Authors:  Priyanka Bajaj; Pawan Kumar Kanaujia; Nambram Somendro Singh; Shalu Sharma; Shakti Kumar; Jugsharan Singh Virdi
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-26       Impact factor: 4.223

5.  Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.

Authors:  Muniqui S Capett; Patricia Vollú-Silva; Vanessa A Melchiades; Luciana C Bokehi; Fernanda M Araújo; Ianick Souto Martins; Felipe P G Neves; Alice G M Gonzalez; Eric Oswald; Geraldo R de Paula; Lenise A Teixeira
Journal:  Curr Microbiol       Date:  2016-07-26       Impact factor: 2.188

6.  Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

Authors:  V Pascual; N Alonso; M Simó; G Ortiz; M C Garcia; M Xercavins; A Rivera; M A Morera; E Miró; E Espejo; F Navarro; M Gurguí; J Pérez; M Rodríguez-Carballeira; J Garau; E Calbo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-22       Impact factor: 3.267

7.  'Supermutators' found amongst highly levofloxacin-resistant E. coli isolates: a rapid protocol for the detection of mutation sites.

Authors:  Ahmed Abdel-Fattah Zayed; Tamer Mohamed Essam; Abdel-Gawad Mohamed Hashem; Ossama Mohamed El-Tayeb
Journal:  Emerg Microbes Infect       Date:  2015-01-28       Impact factor: 7.163

8.  Characteristics of Quinolone Resistance in Escherichia coli Isolates from Humans, Animals, and the Environment in the Czech Republic.

Authors:  Magdalena Röderova; Dana Halova; Ivo Papousek; Monika Dolejska; Martina Masarikova; Vojtech Hanulik; Vendula Pudova; Petr Broz; Miroslava Htoutou-Sedlakova; Pavel Sauer; Jan Bardon; Alois Cizek; Milan Kolar; Ivan Literak
Journal:  Front Microbiol       Date:  2017-01-09       Impact factor: 5.640

Review 9.  Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria.

Authors:  Miklos Fuzi; Dora Szabo; Rita Csercsik
Journal:  Front Microbiol       Date:  2017-11-16       Impact factor: 5.640

10.  Genomic analysis of trimethoprim-resistant extraintestinal pathogenic Escherichia coli and recurrent urinary tract infections.

Authors:  Dmitriy Li; Cameron J Reid; Timothy Kudinha; Veronica M Jarocki; Steven P Djordjevic
Journal:  Microb Genom       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.